Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.
The main impediments to clinical application of haematopoietic stem cell (HSC) gene therapy for treatment of haemophilia A are the bone marrow transplant-related risks and the potential for insertional mutagenesis caused by retroviral vectors. To circumvent these limitations, we have adapted a non-myeloablative conditioning regimen and directed factor VIII (FVIII) protein synthesis to B lineage cells using an insulated lentiviral vector containing an immunoglobulin heavy chain enhancer-promoter. Transplantation of lentiviral vector-modified HSCs resulted in therapeutic levels of FVIII in the circulation of all transplanted mice for the duration of the study (six months). Immunostaining of spleen cells showed that the majority of FVIII was synthesised by B220+ B cells and CD138+ plasma cells. Subsequent challenge with recombinant FVIII elicited at most a minor anti-FVIII antibody response, demonstrating induction of immune hyporesponsiveness. All transplant recipients exhibited clot formation and survived tail clipping, indicating correction of their haemophilic phenotype. Therapeutic levels of FVIII could be transferred to secondary recipients by bone marrow transplantation, confirming gene transfer into long-term repopulating HSCs. Moreover, short-term therapeutic FVIII levels could also be achieved in secondary recipients by adoptive transfer of HSC-derived splenic B cells. Our findings support pursuit of B cell-directed protein delivery as a potential clinical approach to treat haemophilia A and other disorders correctable by systemically distributed proteins.
Department of Anatomy and Regenerative Biology, The George Washington University, Washington, DC 20037, USA.
Ali
A
Ramezani
Lynnsey A
LA
Zweier-Renn
Robert G
RG
Hawley
D019264:Adoptive Transfer; D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology / Q000378:metabolism* / Q000637:transplantation; D002454:Cell Differentiation; D019070:Cell Lineage; D004195:Disease Models, Animal; D005169:Factor VIII / Q000235:genetics / Q000378:metabolism*; D015316:Genetic Therapy; D005822:Genetic Vectors; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006467:Hemophilia A / Q000097:blood* / Q000235:genetics / Q000628:therapy*; D006470:Hemorrhage / Q000235:genetics / Q000517:prevention & control; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D016086:Lentivirus / Q000235:genetics*; D051379:Mice; D008817:Mice, Mutant Strains; D011401:Promoter Regions, Genetic; D019076:Transgenes / Q000235:genetics
D007143:Immunoglobulin Heavy Chains; D005169:Factor VIII
Nat Genet. 1995 May;10(1):119-21
7647782
Blood. 2004 Aug 1;104(3):704-10
15073030
Nat Med. 2010 Jan;16(1):123-8
20023635
Blood. 2007 Oct 15;110(8):2855-63
17569821
Transpl Int. 2008 Dec;21(12):1118-35
18954364
Mol Cell Biol. 1997 May;17(5):2658-68
9111336
Mol Biol Cell. 1999 Jul;10(7):2209-19
10397760
Front Biosci. 2002 May 01;7:d1331-7
11991829
Proc Natl Acad Sci U S A. 1983 Oct;80(20):6351-5
6312453
Nat Biotechnol. 2006 Aug;24(8):1017-21
16845377
Stem Cells. 2008 Dec;26(12):3257-66
18787211
J Gene Med. 2004 Dec;6(12):1358-68
15493040
Mol Ther. 2000 Nov;2(5):458-69
11082319
Mol Ther. 2009 Nov;17(11):1919-28
19672245
Br J Haematol. 2010 Sep;150(5):515-28
20573153
Exp Hematol. 2009 Jun;37(6):744-54
19463774
J Gene Med. 2010 Oct;12(10):797-809
20848668
Blood. 2003 Jun 15;101(12):4717-24
12586614
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16298-303
15520381
Br J Haematol. 2006 Jan;132(2):216-29
16398656
Blood. 2009 Jul 16;114(3):526-34
19470695
J Cell Biol. 1987 Dec;105(6 Pt 1):2665-74
3121636
J Thromb Haemost. 2008 Dec;6(12):2095-104
18826393
Blood. 2011 Jan 20;117(3):798-807
21041718
Nat Med. 2008 Jul;14(7):748-55
18542049
Blood. 2004 May 1;103(9):3412-9
14726380
Thromb Haemost. 2008 May;99(5):840-50
18449413
J Thromb Haemost. 2007 Feb;5(2):352-61
17269937
Nature. 2010 Sep 16;467(7313):318-22
20844535
Nature. 1984 Jan 12-18;307(5947):168-70
6361574
Haemophilia. 2010 May;16(102):89-94
20536991
Mol Cell Biochem. 1987 May;75(1):71-6
3627106
Biol Blood Marrow Transplant. 2007 Aug;13(8):913-24
17640595
Blood. 2010 Aug 26;116(8):1235-43
20445020
Thromb Haemost. 2008 May;99(5):851-62
18449414
Mol Ther. 2005 Dec;12(6):1034-42
16226058
J Hematother Stem Cell Res. 2002 Dec;11(6):859-62
12590700
FASEB J. 2006 Jul;20(9):1522-4
16723382
Mol Ther. 2004 Nov;10(5):892-902
15509507
Curr Gene Ther. 2003 Feb;3(1):27-41
12553533
Expert Rev Hematol. 2009 Dec;2(6):673-683
20577574
Blood. 2005 Jun 15;105(12):4865-70
15769892
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2406-10
3031683
Nat Immunol. 2005 Jan;6(1):23-9
15611778
Int Immunol. 1998 Nov;10(11):1703-11
9846699
Mol Ther. 2008 Apr;16(4):718-25
18334985
Curr Protoc Mol Biol. 2002 Nov;Chapter 16:Unit 16.22
18265303
N Engl J Med. 1994 Jan 6;330(1):38-47
8259143
J Clin Invest. 2009 Apr;119(4):964-75
19307726
Methods Mol Biol. 2008;434:183-203
18470646